VYNE Therapeutics VYNE
$ 3.03
4.48%
Quarterly report 2024-Q3
added 11-07-2024
VYNE Therapeutics EV/EBITDA Ratio 2011-2024 | VYNE
Annual EV/EBITDA Ratio VYNE Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-0.407 | -2.05 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-0.407 | -2.05 | -1.23 |